Hematopoiesis derived from induced pluripotent stem cells recapitulates the developmental process of mature red blood cells, thereby enabling the generation of functional mature red blood cells. This resolves the limitations of short storage periods for donor blood and the problem of alloimmunization. the company leverages cutting-edge gene editing technologies to deliver high-purity, scalable blood components, eliminating donor sample variability and accelerating the translation of hematologic therapies from research to clinical application.